Xenetic Biosciences Inc expected to post a loss of $1.13 a share - Earnings Preview

Xenetic Biosciences

08/08/2023 18:01

* Xenetic Biosciences Inc  XBIO.OQ   XBIO.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 10
(estimated). 
    * The Framingham Massachusetts-based  company is expected to
report  a 5.6% increase in revenue to $440 thousand from $416.71
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Xenetic Biosciences
Inc
is for a loss of $1.13 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Xenetic
Biosciences Inc is $40​, above​ its last closing price of $3.60.
​​​

This summary was machine generated August 8 at 17:01 GMT.  All
figures in US dollars  unless otherwise stated